Author(s)

B. S. Kane^1*, M. Dieng¹, B. C. Fall¹, M. Sow¹, A. C. Ndao¹, B. Djiba¹, M. Niasse², N. Diagne¹, A. Faye¹, S. Ndongo¹, A. Pouye¹

¹Department of Internal Medicine, Le Dantec Teaching Hospital; Cheikh Anta DIOP University of DAKAR, Dakar, Senegal.
²Department of Rheumatology, Le Dantec Teaching Hospital; Cheikh Anta DIOP University of DAKAR, Dakar, Senegal.

Introduction: The central, psychiatric and peripheral neurological manifestations of lupus are among the most severe visceral disorders and are grouped under the general term of “neuro-psychiatric systemic lupus erythematosus” (NPSLE). We conducted a cross-sectional observational study within our Department of Internal Medicine aimed at describing the clinical and evolutionary aspects of central neurological disorders of SLE, excluding lupus myelopathy. Patients and Methods: This was a retrospective and observational cross-sectional study carried out from 1 January 2015 to 31 October 2017, in the Department of Internal Medicine of Aristide le Dantec University Hospital in Dakar (Senegal). All patients hospitalized during this period who met the 1997 ACR classification criteria of SLE and who presented with a central neuropsychiatric syndrome attributable to SLE (as defined by ACR 1999) were included. Patients with isolated headache, acute myelitis or secondary neurological involvement attributable to a toxic, metabolic, infectious or tumour-related cause were excluded from our study. Results: During the study period, 10 patients with neuropsychiatric lupus involvement were treated at our institution, including 9 women and 1 man; the median age was 29 years (20 - 55 years). Neurological involvement occurred during the course of lupus evolution in 9/10 cases. The median time to SLE evolution was 18 months (0 - 60 months). Neuropsychiatric syndromes as defined by the 1999 ACR were commonly associated and more than half of our patients had multiple neuropsychiatric syndromes. There were 5 cases of confusion syndrome and coma, 4 cases of seizure, 3 cases of psychosis, 2 cases of acute cerebrovascular disease and 1 case of aseptic meningitis. Among the extra-neurological manifestations of SLE, haematological and dermatological involvements were common. Renal involvement affected half of the patients. The other manifestations were: polyarthritis in 3 patients, serositis in 2 patients, 5 cases of fever, 4 cases of deterioration of the general state, and one isolated case of ophthalmological involvement. Therapeutically, 8 patients received a bolus of methylprednisolone and 3 patients received a bolus of cyclophosphamide. Oral corticosteroids and hydroxychloroquine were administered to all patients, and azathioprine was administered in 2 patients. The evolution was favorable in 4 patients, other 2 patients maintained neurological sequelae and 2 patients were transferred to intensive care. Death was recorded in 4 patients. Conclusion: Neuropsychiatric manifestations of lupus are rare and sometimes severe, potentially life-threatening. In our patients, we have identified some of the most severe neurological syndromes according to the ACR nomenclature. The neurological involvement is exceptionally revealing, as these syndromes are often associated and integrated into a systemic context of lupus. The evolution is rapidly unfavorable and requires early diagnosis and optimal management.

Systemic Lupus Erythematosus, Lupus Vasculitis, Central Nervous System, Africa South of the Sahara

Kane, B. , Dieng, M. , Fall, B. , Sow, M. , Ndao, A. , Djiba, B. , Niasse, M. , Diagne, N. , Faye, A. , Ndongo, S. and Pouye, A. (2019) Neurological Involvement in Systemic Lupus Erythematosus (SLE): Our Recent Experience. Open Journal of Rheumatology and Autoimmune Diseases, 9, 25-34. doi: 10.4236/ojra.2019.92003.